[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581566":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":41,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":10,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":10,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Centre Antoine Lacassagne","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"principal",null,"blood sampling",[13],"Other: blood sampling",[15],{"type":6,"name":11,"description":16,"armGroupLabels":17,"otherNames":10},"36ml of blood will be taken during a blood sampling performed in standard practice",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Victoria FERRARI, Dr","CONTACT","+33 492031311","victoria.ferrari@nice.unicancer.fr",[25],{"facility":5,"status":26,"city":27,"state":10,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","Nice","0600","France","FR",{"type":32,"coordinates":33},"Point",[34,35],7.26608,43.70313,{"lat":35,"lon":34},[38],{"name":39,"role":21,"phone":40,"phoneExt":10,"email":23},"Victoria FERRARI","+33492031311",{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100581566","research-into-biomarkers-predictive-of-survival-and-response-to-cancer-treatment-100581566",false,"NCT06851975","Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment","BEST","Inclusion Criteria:\n\n* Patient having a blood test, venous line insertion or injection on an implantable venous device scheduled as part of their standard care,\n* Patient who has read the information note and stated that he\u002Fshe has no objections\n* Patient who has not objected to the use of this data for medical research purposes\n* Patient with social security cover.\n\nExclusion Criteria:\n\n* Patient already included in the study\n* Patient considered to be a vulnerable person; vulnerable persons are defined in article L1121-5 to -8","ALL","18 Years",{"count":53,"type":54},40000,"ESTIMATED","OBSERVATIONAL","Research into biomarkers predictive of survival and response to cancer treatment",[58],"Cancer","2026-05-27",{"date":61,"type":62},"2026-05-29","ACTUAL",{"date":64,"type":62},"2020-01-07",{"date":66,"type":54},"2099-12-31",{"name":5,"class":6},1]